叮噹健康攜手諾和諾德上架"體重管理版"司美格魯肽 助力提升用藥可及性
日前,叮噹健康與諾和諾德宣佈達成戰略合作,隆重舉行線下合作儀式,雙方將充分發揮各自在醫療健康領域的資源優勢,共同打造集疾病科普教育、健康體重評估、線上健康諮詢等在內的全週期體重健康管理解決方案。現場邀請到多位內分泌科專家為叮噹多功能智慧藥房藥師展開系統化培訓,提升叮噹專業服務能力。

圖:叮噹健康&諾和諾德北京戰略啟動會
"本次合作,希望充分發揮諾和諾德深耕慢病領域的專業經驗和創新治療方案以及叮噹健康專業服務優勢,為健康管理患者提高用藥可及性,助力解決有關體重管理的公共衞生問題",諾和諾德華北零售大區經理苗陽先生介紹。

圖:叮噹健康&諾和諾德戰略啟動儀式
"為確保用藥的有效性和安全性,我們聯合諾和諾德邀請到內分泌科專家為叮噹多功能智慧藥房的藥師展開系統化培訓,幫助藥師迅速、準確地掌握產品特點和專業知識,在安全、合規的前提下,更好地為符合適應症患者提供專業服務",叮噹健康相關負責人表示,"我們也將持續加強叮噹冷鏈藥品的佈局及服務,提升叮噹多功能智慧藥房的專業化屬性"。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.